Yuki Tsuji

Kashihara-shi, 6348521, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 97 publications

Correction: Nishimura et al. Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut-Liver Axis and Epiregulin-IL-8-Associated Angiogenesis. Int. J. Mol. Sci. 2025, 26, 6710.

Correction: Nishimura et al. Rifaximin Attenuates Liver Fibrosis and Hepatocarcinogenesis in a Rat MASH Model by Suppressing the Gut-Liver Axis and Epiregulin-IL-8-Associated Angiogenesis. Int. J. Mol. Sci. 2025, 26, 6710.

Journal: International journal of molecular sciences

Published: July 28, 2026

Response to "Comment on 'Using Serum Creatinine-To-Cystatin C Ratio to Predict Sarcopenia in Patients With Liver Cirrhosis'".

Response to "Comment on 'Using Serum Creatinine-To-Cystatin C Ratio to Predict Sarcopenia in Patients With Liver Cirrhosis'".

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: June 21, 2026

Long-Term Effects of Nalmefene on Alcohol Consumption, Liver Function, and Gut Microbiota in Patients With Alcohol-Related Liver Disease.

Long-Term Effects of Nalmefene on Alcohol Consumption, Liver Function, and Gut Microbiota in Patients With Alcohol-Related Liver Disease.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 18, 2026

Impact of the Number of Remaining Natural Teeth on Decompensation and Survival in Patients With Compensated Liver Cirrhosis.

Impact of the Number of Remaining Natural Teeth on Decompensation and Survival in Patients With Compensated Liver Cirrhosis.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: April 14, 2026

Glucosyl hesperidin benefits in primary biliary cholangitis: a multicenter, open-label, randomized controlled study.

Glucosyl hesperidin benefits in primary biliary cholangitis: a multicenter, open-label, randomized controlled study.

Journal: Clinical and translational gastroenterology

Published: February 24, 2026

Dual Escape From Ferroptosis and Disulfidptosis Denotes a Hypermetabolic, High-Risk Subtype of Hepatocellular Carcinoma.

Dual Escape From Ferroptosis and Disulfidptosis Denotes a Hypermetabolic, High-Risk Subtype of Hepatocellular Carcinoma.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: February 18, 2026

Creatinine/Cystatin C Ratio as a Surrogate Marker for Sarcopenia in Hepatitis-C-Associated Liver Cirrhosis After Achieving a Sustained Virologic Response.

Creatinine/Cystatin C Ratio as a Surrogate Marker for Sarcopenia in Hepatitis-C-Associated Liver Cirrhosis After Achieving a Sustained Virologic Response.

Journal: Current issues in molecular biology

Published: January 06, 2026

Validation of Nonselective Conservative Treatment for Pediatric Acute Appendicitis.

Validation of Nonselective Conservative Treatment for Pediatric Acute Appendicitis.

Journal: Pediatrics international : official journal of the Japan Pediatric Society

Published: January 04, 2026

Third-Generation Narrow-Band Imaging Versus White-Light Imaging for the Detection of Early Gastric Cancer: A Randomized Controlled Study.

Third-Generation Narrow-Band Imaging Versus White-Light Imaging for the Detection of Early Gastric Cancer: A Randomized Controlled Study.

Journal: DEN open

Published: November 14, 2025

Clinical Significance of Intratumoral Contrast Pooling on Contrast-Enhanced CT After Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.

Clinical Significance of Intratumoral Contrast Pooling on Contrast-Enhanced CT After Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma.

Journal: Current oncology (Toronto, Ont.)

Published: November 06, 2025

Diabetes as a Risk Factor for Sarcopenia in Patients with MASH-Related Cirrhosis.

Diabetes as a Risk Factor for Sarcopenia in Patients with MASH-Related Cirrhosis.

Journal: Journal of clinical medicine

Published: October 20, 2025

The 7S Domain of Type IV Collagen as a Noninvasive Surrogate of Portal Hypertension.

The 7S Domain of Type IV Collagen as a Noninvasive Surrogate of Portal Hypertension.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: September 27, 2025

Showing 1-12 of 97

Last Updated: 09/26/2026